Vedovato M - Search Results

1

Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes.

Tessari P, Biolo G, Bruttomesso D, Inchiostro S, Panebianco G, Vedovato M, Fongher C, Tiengo A. Tessari P, et al. Among authors: vedovato m. J Clin Endocrinol Metab. 1994 Dec;79(6):1553-60. doi: 10.1210/jcem.79.6.7989455. J Clin Endocrinol Metab. 1994. PMID: 7989455 Clinical Trial.

2

Insulin resistance of amino acid and protein metabolism in type 2 diabetes.

Tessari P, Cecchet D, Cosma A, Puricelli L, Millioni R, Vedovato M, Tiengo A. Tessari P, et al. Among authors: vedovato m. Clin Nutr. 2011 Jun;30(3):267-72. doi: 10.1016/j.clnu.2011.02.009. Epub 2011 Apr 13. Clin Nutr. 2011. PMID: 21492974 Review.

3

Accelerated whole-body protein catabolism in subjects with type 2 Diabetes Mellitus and albuminuria.

Zanetti M, Barazzoni R, Kiwanuka E, Vettore M, Vedovato M, Tessari P. Zanetti M, et al. Among authors: vedovato m. PLoS One. 2020 Dec 17;15(12):e0243638. doi: 10.1371/journal.pone.0243638. eCollection 2020. PLoS One. 2020. PMID: 33332405 Free PMC article.

4

Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria.

Trevisan R, Bruttomesso D, Vedovato M, Brocco S, Pianta A, Mazzon C, Girardi C, Jori E, Semplicini A, Tiengo A, Del Prato S. Trevisan R, et al. Among authors: vedovato m. Diabetes. 1998 Aug;47(8):1347-53. doi: 10.2337/diab.47.8.1347. Diabetes. 1998. PMID: 9703338

5

The epidemiology of diabetes mellitus.

Trevisan R, Vedovato M, Tiengo A. Trevisan R, et al. Among authors: vedovato m. Nephrol Dial Transplant. 1998;13 Suppl 8:2-5. doi: 10.1093/ndt/13.suppl_8.2. Nephrol Dial Transplant. 1998. PMID: 9870417 Review.

6

Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes.

Parvanova A, Iliev I, Filipponi M, Dimitrov BD, Vedovato M, Tiengo A, Trevisan R, Remuzzi G, Ruggenenti P. Parvanova A, et al. Among authors: vedovato m. J Clin Endocrinol Metab. 2004 Sep;89(9):4371-6. doi: 10.1210/jc.2003-032076. J Clin Endocrinol Metab. 2004. PMID: 15356034

7

Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects.

Puricelli L, Iori E, Millioni R, Arrigoni G, James P, Vedovato M, Tessari P. Puricelli L, et al. Among authors: vedovato m. J Clin Endocrinol Metab. 2006 Sep;91(9):3507-14. doi: 10.1210/jc.2006-0274. Epub 2006 Jul 5. J Clin Endocrinol Metab. 2006. PMID: 16822825

8

Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy.

Tessari P, Coracina A, Kiwanuka E, Vedovato M, Vettore M, Valerio A, Zaramella M, Garibotto G. Tessari P, et al. Among authors: vedovato m. Diabetes. 2005 Oct;54(10):2968-76. doi: 10.2337/diabetes.54.10.2968. Diabetes. 2005. PMID: 16186400

9

Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy.

Tessari P, Cecchet D, Cosma A, Vettore M, Coracina A, Millioni R, Iori E, Puricelli L, Avogaro A, Vedovato M. Tessari P, et al. Among authors: vedovato m. Diabetes. 2010 Sep;59(9):2152-9. doi: 10.2337/db09-1772. Epub 2010 May 18. Diabetes. 2010. PMID: 20484137 Free PMC article.

10

Abnormal cytoskeletal protein expression in cultured skin fibroblasts from type 1 diabetes mellitus patients with nephropathy: A proteomic approach.

Millioni R, Iori E, Puricelli L, Arrigoni G, Vedovato M, Trevisan R, James P, Tiengo A, Tessari P. Millioni R, et al. Among authors: vedovato m. Proteomics Clin Appl. 2008 Apr;2(4):492-503. doi: 10.1002/prca.200780112. Epub 2008 Mar 7. Proteomics Clin Appl. 2008. PMID: 21136853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters